The newsboard processes news from the NASDAQ Nordic portfolio company GlobeNewswire, which provides investors with company-relevant information. This relates in particular to events that may be relevant to the listing of companies or tradable financial instruments.
GlobNewswire (formerly PrimeNewswire) specializes in public relations solutions and digital media services. This feed adds another important source of information for investors to the popular X-Billboard portfolio.
Allschwil, Switzerland – November 11, 2024
Ad hoc announcement pursuant to Art. 53 LR
Allschwil, Switzerland – October 16, 2024
Ad hoc announcement pursuant to Art. 53 LR
Idorsia will publish its Half Year 2024 Financial Reporting on Thursday July 25, 2024, at 07:00 CEST.
Allschwil, Switzerland – July 1, 2024
Idorsia Ltd (SIX: IDIA) announced today that the European Commission (EC) has approved JERAYGO™ (aprocitentan) for the treatment of resistant hypertension in adult patients in combination with at least three antihypertensive medicinal products.1 The recommended dose is 12.5 mg orally once daily. The dose can be increased to 25 mg once daily for patients tolerating the 12.5 mg dose and in need of tighter blood pressure (BP) control.1
Allschwil, Switzerland – June 28, 2024
Ad hoc announcement pursuant to Art. 53 LR
Allschwil, Switzerland – June 21, 2024
Idorsia Ltd (SIX: IDIA) announced today that its novel treatment for chronic insomnia has been awarded the prestigious Prix Galien Suisse 2024 innovation prize in the ‘Primary & Speciality’ category. The Prix Galien Suisse is awarded annually to the most innovative new medicines and diagnostics on the Swiss market, as judged by a jury of renowned Swiss scientists.
Allschwil, Switzerland – June 13, 2024
At today’s Annual General Meeting (AGM) of Idorsia Ltd (SIX: IDIA) held in Basel, Switzerland, shareholders voted in favor of all proposals by the Board of Directors with very large majorities.
Allschwil, Switzerland – June 3, 2024
Allschwil, Switzerland – May 31, 2024
Allschwil, Switzerland – May 23, 2024
Ad hoc announcement pursuant to Art. 53 LR
Ad hoc announcement pursuant to Art. 53 LR
Ad hoc announcement pursuant to Art. 53 LR
Ad hoc announcement pursuant to Art. 53 LR
Ad hoc announcement pursuant to Art. 53 LR
The information provided here is not subject to any editorial processing. It is prepared fully automatically and enriched with additional information and further research options. The aim of the content is to provide information seekers with the relevant information quickly and easily. A link back to the information provider and owner ensures that the data prepared here can be compared with the source information if required. The newsboard does not show information in real time. Please contact the exchange operator for this information if required. There is no claim to completeness. High availability cannot be guaranteed. If you notice any errors in the functionality, please let us know using the "Report a Bug" form below.
RAW DATA PROCESSING means that raw data is processed without changing the content. The data is supplemented to improve the interpretation of the information in terms of usability.
Note: The newswire cross-link panel at the top allows you to quickly and easily access additional sources of information. In the terminal view, the news is filtered at company level and enables targeted searches.
On behalf of the trading community, we would like to thank the operators of the trading venues for providing information services.